| Q1 2024 |
655 |
$5.88B |
+$654M |
-$640M |
+$14.3M |
BAC, VZ, GOOGL, MSFT, NTAP, MTCH |
13F-HR |
5/8/2024, 04:13 PM |
| Q4 2023 |
677 |
$5.55B |
+$596M |
-$415M |
+$180M |
BAC, VZ, GOOGL, MSFT, NTAP, AKAM |
13F-HR |
2/12/2024, 01:29 PM |
| Q3 2023 |
744 |
$4.92B |
+$340M |
-$384M |
-$44.3M |
BAC, VZ, MSFT, GOOGL, NTAP, AKAM |
13F-HR |
11/13/2023, 03:19 PM |
| Q2 2023 |
711 |
$5.04B |
+$812M |
-$355M |
+$457M |
MSFT, BAC, VZ, GOOGL, NTAP, AMZN |
13F-HR |
8/9/2023, 10:13 AM |
| Q1 2023 |
723 |
$4.37B |
+$486M |
-$513M |
-$26.9M |
MSFT, GOOGL, BAC, VZ, NTAP, AMZN |
13F-HR |
5/11/2023, 12:43 PM |
| Q4 2022 |
777 |
$4.26B |
+$457M |
-$271M |
+$186M |
MSFT, BAC, GOOGL, NTAP, VZ, MRK |
13F-HR |
2/9/2023, 05:07 AM |
| Q3 2022 |
803 |
$3.73B |
+$362M |
-$263M |
+$98.8M |
BAC, MSFT, GOOGL, AMZN, NTAP, SPY |
13F-HR |
11/9/2022, 08:57 AM |
| Q2 2022 |
789 |
$4.08B |
+$692M |
-$362M |
+$329M |
MSFT, GOOGL, BAC, VZ, NTAP, AMZN |
13F-HR |
8/12/2022, 11:49 AM |
| Q1 2022 |
800 |
$4.54B |
+$625M |
-$432M |
+$193M |
MSFT, BAC, GOOGL, AMZN, NTAP, VZ |
13F-HR |
5/10/2022, 12:08 PM |
| Q4 2021 |
806 |
$4.62B |
+$606M |
-$432M |
+$174M |
MSFT, GOOGL, BAC, AMZN, JPM, STLA |
13F-HR |
2/10/2022, 07:28 AM |
| Q3 2021 |
814 |
$4.32B |
+$449M |
-$273M |
+$175M |
MSFT, BAC, GOOGL, STLA, AMZN, CVS |
13F-HR |
11/12/2021, 06:52 AM |
| Q2 2021 |
785 |
$4.33B |
+$640M |
-$215M |
+$425M |
BABA, MSFT, BAC, GOOGL, CVS, STLA |
13F-HR |
8/11/2021, 01:51 PM |
| Q1 2021 |
716 |
$3.65B |
+$786M |
-$223M |
+$563M |
BABA, MSFT, BAC, GOOGL, STLA, AMZN |
13F-HR |
5/17/2021, 01:33 PM |
| Q4 2020 |
633 |
$2.98B |
+$449M |
-$309M |
+$140M |
BABA, MSFT, AMZN, GOOGL, CVS, BAC |
13F-HR |
2/12/2021, 11:23 AM |
| Q3 2020 |
603 |
$2.52B |
+$255M |
-$286M |
-$30.4M |
BABA, MSFT, AMZN, GOOGL, MRK, IBM |
13F-HR |
11/12/2020, 10:36 AM |
| Q2 2020 |
599 |
$2.43B |
+$323M |
-$173M |
+$150M |
BABA, MSFT, AMZN, IBM, CVS, GOOGL |
13F-HR |
8/7/2020, 06:01 PM |
| Q1 2020 |
568 |
$1.91B |
+$254M |
-$236M |
+$17.5M |
BABA, IBM, MSFT, GILD, CVS, SPY |
13F-HR |
5/15/2020, 09:46 AM |
| Q4 2019 |
570 |
$2.53B |
+$225M |
-$351M |
-$126M |
CVS, BAC, IBM, SPY, BABA, GILD |
13F-HR |
2/14/2020, 08:13 AM |
| Q3 2019 |
568 |
$2.5B |
+$220M |
-$305M |
-$84.5M |
CVS, BAC, IBM, SPY, GILD, JPM |
13F-HR |
11/14/2019, 01:41 PM |
| Q2 2019 |
567 |
$2.66B |
+$214M |
-$471M |
-$257M |
BAC, GILD, IBM, CVS, QGEN, JPM |
13F-HR |
8/14/2019, 11:11 AM |
| Q1 2019 |
600 |
$2.89B |
+$190M |
-$429M |
-$239M |
AGN, BAC, IBM, GILD, IEF, QGEN |
13F-HR |
5/13/2019, 02:44 PM |
| Q4 2018 |
658 |
$2.85B |
+$324M |
-$316M |
+$8.03M |
QGEN, BAC, SPY, AGN, GILD, IEF |
13F-HR |
2/14/2019, 05:39 AM |
| Q3 2018 |
719 |
$3.51B |
+$246M |
-$358M |
-$112M |
QGEN, AGN, BAC, C, PFE, GILD |
13F-HR |
11/14/2018, 09:36 AM |
| Q2 2018 |
724 |
$3.49B |
+$335M |
-$328M |
+$6.9M |
AGN, QGEN, BAC, GILD, C, PFE |
13F-HR |
8/14/2018, 01:00 PM |
| Q1 2018 |
748 |
$3.42B |
+$416M |
-$358M |
+$58.2M |
AGN, BAC, GILD, C, QGEN, MET |
13F-HR |
5/15/2018, 03:57 PM |
| Q4 2017 |
755 |
$3.43B |
+$434M |
-$500M |
-$65.6M |
AGN, BAC, GILD, C, PFE, CVX |
13F-HR |
2/14/2018, 12:28 PM |
| Q3 2017 |
792 |
$3.46B |
+$283M |
-$259M |
+$24.8M |
GILD, AGN, BAC, C, PFE, MET |
13F-HR |
11/13/2017, 11:31 AM |
| Q2 2017 |
779 |
$3.51B |
+$304M |
-$479M |
-$175M |
AGN, BAC, GILD, MET, PFE, C |
13F-HR |
8/10/2017, 03:34 PM |
| Q1 2017 |
795 |
$3.73B |
+$398M |
-$321M |
+$77.2M |
AGN, BAC, MET, PFE, GILD, C |
13F-HR |
5/15/2017, 11:14 AM |
| Q4 2016 |
792 |
$3.56B |
+$576M |
-$315M |
+$261M |
BAC, AGN, MET, PFE, GILD, CVX |
13F-HR |
2/14/2017, 10:14 AM |
| Q3 2016 |
815 |
$3.27B |
+$483M |
-$390M |
+$93.6M |
BAC, C, MET, GLD, GILD, CVX |
13F-HR |
11/14/2016, 01:34 PM |
| Q2 2016 |
790 |
$3.11B |
+$325M |
-$376M |
-$50.4M |
C, BAC, MET, CVX, AGN, GLD |
13F-HR |
8/10/2016, 11:41 AM |
| Q1 2016 |
794 |
$3.13B |
+$291M |
-$729M |
-$438M |
C, MET, BAC, CVX, JPM, MRK |
13F-HR |
5/12/2016, 05:19 PM |
| Q4 2015 |
796 |
$3.74B |
+$395M |
-$501M |
-$106M |
C, MRK, MET, BAC, JPM, ESRX |
13F-HR |
2/16/2016, 11:04 AM |
| Q3 2015 |
808 |
$3.88B |
+$358M |
-$447M |
-$89.8M |
C, MET, MRK, JPM, UBS, BAC |
13F-HR |
11/16/2015, 03:29 PM |
| Q2 2015 |
801 |
$4.65B |
|
|
|
C, UBS, MET, MRK, JPM, MDT |
13F-HR |
8/7/2015, 01:38 PM |